• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

爱尔兰医院获得性血流感染的归因死亡率。

Attributable mortality of hospital-acquired bloodstream infections in Ireland.

作者信息

Brady M, Oza A, Cunney R, Burns K

机构信息

Health Protection Surveillance Centre, Dublin, Ireland; Department of Clinical Microbiology, Beaumont Hospital, Dublin, Ireland.

Health Protection Surveillance Centre, Dublin, Ireland.

出版信息

J Hosp Infect. 2017 May;96(1):35-41. doi: 10.1016/j.jhin.2017.02.006. Epub 2017 Feb 9.

DOI:10.1016/j.jhin.2017.02.006
PMID:28359546
Abstract

AIM

To estimate the attributable mortality of hospital-acquired bloodstream infections (HA-BSI) in Ireland.

METHODS

A retrospective case-cohort study was conducted, based on notifications from Irish microbiology laboratories and administrative patient records from six Irish hospitals from January 2007 to December 2013. Probabilistic linkage was used to link 1252 cases of bloodstream infection from a cohort of 343,189 hospitalized patients. Independent predictors of mortality were determined using a multi-variable logistic regression model, and included: patient age, emergency or re-admission to hospital, length of stay in an intensive care unit, number of procedures, number of diagnoses, major diagnostic category and presence of HA-BSI.

RESULTS

Attributable mortality was calculated from the crude mortality of case subjects after adjusting for other predictors of mortality, and was found to be 15.3% (95% confidence interval 14.8-15.8%). The study was further stratified according to the causative organism, including: Escherichia coli, Enterococcus faecium, Enterococcus faecalis, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus pneumoniae, and, where available, their antimicrobial resistance patterns. The highest attributable mortality among these organisms was reported for E. faecium at 18.1% and the lowest attributable mortality was reported for E. coli at 13.6%. A significantly higher attributable mortality was found for antimicrobial resistance patterns of some organisms, most notably for meticillin-resistant S. aureus at 19.5%, vs meticillin-susceptible S. aureus at 13.3%.

CONCLUSIONS

HA-BSI is an important cause of mortality, and attributable mortality differs significantly among causative organisms and antimicrobial resistance patterns.

摘要

目的

评估爱尔兰医院获得性血流感染(HA-BSI)的归因死亡率。

方法

进行了一项回顾性病例队列研究,数据来源于爱尔兰微生物实验室的报告以及2007年1月至2013年12月期间爱尔兰六家医院的患者管理记录。采用概率性链接方法,将来自343,189名住院患者队列中的1252例血流感染病例进行链接。使用多变量逻辑回归模型确定死亡率的独立预测因素,包括:患者年龄、急诊或再次入院、重症监护病房住院时间、手术数量、诊断数量、主要诊断类别以及是否存在HA-BSI。

结果

在对其他死亡率预测因素进行调整后,根据病例组的粗死亡率计算出归因死亡率为15.3%(95%置信区间14.8-15.8%)。该研究进一步根据病原体进行分层,包括:大肠杆菌、粪肠球菌、屎肠球菌、铜绿假单胞菌、肺炎克雷伯菌、金黄色葡萄球菌和肺炎链球菌,以及在可行情况下它们的抗菌药物耐药模式。这些病原体中,屎肠球菌的归因死亡率最高,为18.1%,大肠杆菌的归因死亡率最低,为13.6%。发现某些病原体的抗菌药物耐药模式的归因死亡率显著更高,最明显的是耐甲氧西林金黄色葡萄球菌为19.5%,而甲氧西林敏感金黄色葡萄球菌为13.3%。

结论

HA-BSI是导致死亡的重要原因,不同病原体和抗菌药物耐药模式的归因死亡率存在显著差异。

相似文献

1
Attributable mortality of hospital-acquired bloodstream infections in Ireland.爱尔兰医院获得性血流感染的归因死亡率。
J Hosp Infect. 2017 May;96(1):35-41. doi: 10.1016/j.jhin.2017.02.006. Epub 2017 Feb 9.
2
Antimicrobial resistance of pathogens causing nosocomial bloodstream infection in Hubei Province, China, from 2014 to 2016: a multicenter retrospective study.2014 年至 2016 年中国湖北省医院血流感染病原菌的耐药性:一项多中心回顾性研究。
BMC Public Health. 2018 Sep 15;18(1):1121. doi: 10.1186/s12889-018-6013-5.
3
Bloodstream infections in pediatric patients.儿科患者的血流感染
Saudi Med J. 2005 Oct;26(10):1555-61.
4
Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities.美国医院儿科患者的医院血流感染:流行病学、临床特征及药敏情况
Pediatr Infect Dis J. 2003 Aug;22(8):686-91. doi: 10.1097/01.inf.0000078159.53132.40.
5
Unique characteristics of community-onset healthcare- associated bloodstream infections: a multi-centre prospective surveillance study of bloodstream infections in Japan.社区获得性医疗保健相关血流感染的独特特征:日本血流感染的多中心前瞻性监测研究
J Hosp Infect. 2017 May;96(1):29-34. doi: 10.1016/j.jhin.2017.02.022. Epub 2017 Feb 27.
6
Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002).哨兵抗菌监测计划(1997 - 2002年)血流感染分离株的发生率及抗菌药物耐药模式比较
Diagn Microbiol Infect Dis. 2004 Sep;50(1):59-69. doi: 10.1016/j.diagmicrobio.2004.05.003.
7
Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study.挪威中部一家综合医院血流感染的抗菌药物耐药性及经验性抗生素治疗趋势:一项前瞻性观察研究。
BMC Infect Dis. 2017 Feb 2;17(1):116. doi: 10.1186/s12879-017-2210-6.
8
[Epidemiology of nosocomial bloodstream infections in Polish hospitals].[波兰医院医院血流感染的流行病学]
Przegl Epidemiol. 2004;58(2):253-64.
9
Klebsiella pneumoniae bloodstream infection, antimicrobial resistance and consumption trends in Ireland: 2008 to 2013.爱尔兰2008年至2013年肺炎克雷伯菌血流感染、抗菌药物耐药性及使用趋势
Eur J Clin Microbiol Infect Dis. 2016 Nov;35(11):1777-1785. doi: 10.1007/s10096-016-2727-4. Epub 2016 Aug 4.
10
Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study.入住欧洲重症监护病房的患者的医疗保健相关感染和抗菌药物耐药的临床结局:一项队列研究。
Lancet Infect Dis. 2011 Jan;11(1):30-8. doi: 10.1016/S1473-3099(10)70258-9. Epub 2010 Dec 2.

引用本文的文献

1
Comparative Assessment of Rapid Identification and Antimicrobial Susceptibility Testing Methods for Bloodstream Infections in a Non-24/7 Clinical Microbiology Laboratory.非全天候临床微生物实验室中血流感染快速鉴定及药敏试验方法的比较评估
Microorganisms. 2025 Apr 30;13(5):1041. doi: 10.3390/microorganisms13051041.
2
Escherichia coli causing bloodstream infections in Mexican paediatric patients: molecular typing, antimicrobial resistance, virulence factors, and clinical features.引起墨西哥儿科患者血流感染的大肠杆菌:分子分型、抗菌药物耐药性、毒力因子及临床特征
BMC Infect Dis. 2025 May 27;25(1):764. doi: 10.1186/s12879-025-11163-3.
3
Comparison of morbidity and mortality after bloodstream infection with vancomycin-resistant versus -susceptible nationwide cohort study in Denmark, 2010-2019.
2010 - 2019年丹麦全国队列研究:耐万古霉素与敏感血流感染后的发病率和死亡率比较
Emerg Microbes Infect. 2024 Dec;13(1):2309969. doi: 10.1080/22221751.2024.2309969. Epub 2024 Mar 11.
4
Epidemiology of Bloodstream Infections and Antimicrobial Susceptibility Pattern in ICU and Non-ICU Wards: A Four-Year Retrospective Study in Isfahan, Iran.重症监护病房和非重症监护病房血流感染的流行病学及抗菌药物敏感性模式:伊朗伊斯法罕的一项四年回顾性研究
Adv Biomed Res. 2023 Apr 27;12:106. doi: 10.4103/abr.abr_320_22. eCollection 2023.
5
Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections.万古霉素耐药肠球菌血流感染的治疗方法。
Clin Microbiol Rev. 2023 Jun 21;36(2):e0005922. doi: 10.1128/cmr.00059-22. Epub 2023 Apr 17.
6
Hospital-acquired infections caused by enterococci: a systematic review and meta-analysis, WHO European Region, 1 January 2010 to 4 February 2020.肠球菌引起的医院获得性感染:系统评价和荟萃分析,2010 年 1 月 1 日至 2020 年 2 月 4 日,世卫组织欧洲区域。
Euro Surveill. 2021 Nov;26(45). doi: 10.2807/1560-7917.ES.2021.26.45.2001628.
7
Predictive factors of in-hospital mortality in patients with laboratory-confirmed Escherichia coli, Klebsiella species or Pseudomonas aeruginosa bloodstream infections.实验室确诊的大肠埃希菌、克雷伯菌属或铜绿假单胞菌血流感染患者住院死亡率的预测因素。
PLoS One. 2021 Nov 2;16(11):e0259305. doi: 10.1371/journal.pone.0259305. eCollection 2021.
8
Distribution of pathogens and antimicrobial resistance in ICU-bloodstream infections during hospitalization: a nationwide surveillance study.住院期间 ICU-血流感染的病原体分布和抗菌药物耐药性:一项全国性监测研究。
Sci Rep. 2021 Aug 19;11(1):16876. doi: 10.1038/s41598-021-95873-z.
9
Low Proportion of Linezolid and Daptomycin Resistance Among Bloodborne Vancomycin-Resistant and Methicillin-Resistant Infections in Europe.欧洲血源感染中耐万古霉素和耐甲氧西林感染里利奈唑胺和达托霉素耐药比例较低
Front Microbiol. 2021 May 31;12:664199. doi: 10.3389/fmicb.2021.664199. eCollection 2021.
10
Mortality review as a tool to assess the contribution of healthcare-associated infections to death: results of a multicentre validity and reproducibility study, 11 European Union countries, 2017 to 2018.死亡率审核作为评估医疗保健相关感染导致死亡的工具:11 个欧盟国家,2017 至 2018 年多中心有效性和可重复性研究的结果。
Euro Surveill. 2021 Jun;26(23). doi: 10.2807/1560-7917.ES.2021.26.23.2000052.